Medtronic has achieved a major milestone with the U.S. Food and Drug Administration (FDA) granting approval for its Affera Mapping and Ablation System, including the Sphere-9 catheter. This approval, announced on 24 October 2024, positions Medtronic as the first and only company to offer dual-energy pulsed field ablation (PFA) and radiofrequency (RF) technologies for atrial […]
Boston Scientific Corporation (NYSE: BSZ) has announced its definitive agreement to acquire Silk Road Medical, Inc. (Nasdaq: SILK) for $27.50 per share, reflecting an enterprise value of approximately $1.16 billion. This transaction, which is a 38% premium over the volume-weighted average share price of Silk Road Medical’s stock over the past 60 days, is expected […]
Boston Scientific Corporation (NYSE: BSX) has entered into a definitive agreement to acquire Axonics, Inc. (Nasdaq: AXNX), a leading medical technology company specializing in urinary and bowel dysfunction devices. The acquisition, valued at $71 per share in cash, reflects an equity value of approximately $3.7 billion and an enterprise value of about $3.4 billion. Addressing […]
Boston Scientific Corporation has struck a definitive deal to purchase Relievant Medsystems for an upfront payment of $850 million. Additional undisclosed contingent payments are also agreed upon based on Relievant Medsystems’ sales performance over the next three years. FDA-Approved Intracept System a Game-Changer for Vertebrogenic Pain The acquisition includes the Intracept Intraosseous Nerve Ablation System, […]
Boston Scientific, a US medical device maker, has offered to acquire a stake of up to 65% in Chinese medical technology company Acotec Scientific for a sum of around $523 million. Acotec Scientific offers solutions for vascular interventional and other diseases treatment, including drug-coated balloons and percutaneous transluminal angioplasty balloon catheter. With over 20 other […]
Boston Scientific has agreed to acquire Texas-based medical technology company Apollo Endosurgery in an all-cash transaction with an enterprise value of nearly $615 million. As per the terms of the deal, shareholders of the Nasdaq-listed Apollo Endosurgery will be offered $10 per share by Boston Scientific. The deal has been approved unanimously by the company’s […]
Boston Scientific said that the ACURATE neo2 Aortic Valve System delivered a high procedural success rate of 98.4% and low rates of paravalvular leak (PVL) and mortality in a post-market study. The findings are part of the first results from the ACURATE neo2 post market clinical follow-up (PMCF) study that is assessing the performance of […]
Boston Scientific has agreed to acquire Baylis Medical Company, a Canadian medical devices manufacturer in the field of cardiology, for $1.75 billion. The deal does not include Baylis Medical Technologies, which develops medical devices in the fields of neurosurgery and radiology. Through the acquisition of Baylis Medical Company, Boston Scientific will get access to the […]
Boston Scientific has wrapped up the previously announced $1.07 billion acquisition of the global surgical business of Israeli medical solutions provider Lumenis. The US medical device manufacturer had signed the deal in March 2021 with an affiliate of Baring Private Equity Asia (BPEA), which owns Lumenis. The BPEA affiliate will retain ownership of Lumenis’ global […]
Boston Scientific has agreed to acquire the global surgical business of Israel-based energy-based medical solutions provider Lumenis for $1.07 billion in cash. In this connection, Boston Scientific has signed a deal with an affiliate of Baring Private Equity Asia (BPEA), which will retain ownership of the global aesthetics and ophthalmology businesses of Lumenis. The surgical […]